Alerts will be sent to your verified email
Verify Email
BIBCL
|
Bharat Immunological
|
Makers Laboratories
|
Biofil Chem & Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-29.83 % | 0.31 % | 5.42 % |
|
5yr Avg Net Profit Margin
|
-18.38 % | -0.21 % | 2.86 % |
|
Price to Book
|
1.18 | 1.22 | 3.73 |
|
P/E
|
0.0 | 9.69 | 25.0 |
|
5yr Avg Cash Conversion Cycle
|
206.63 Days | 75.08 Days | 65.55 Days |
|
5yr Average Interest Coverage Ratio
|
-2.32 | 4.73 | 21.93 |
|
5yr Avg ROCE
|
-44.64 % | 6.35 % | 7.69 % |
|
5yr Avg Operating Profit Margin
|
-18.7 % | 7.59 % | 4.5 % |
|
5 yr average Debt to Equity
|
0.71 | 0.21 | 0.04 |
|
5yr CAGR Net Profit
|
23.51 % | n/a | -10.11 % |
|
5yr Average Return on Assets
|
-10.1 % | 0.25 % | 2.72 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
59.25 % | 61.27 % | 46.82 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Bharat Immunological
|
Makers Laboratories
|
Biofil Chem & Pharma
|
|---|